Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Dobutamine in Septic Shock Metabolism
NCT02963454Unknown
- Sponsor
- Military Hospital of Tunis
- Start
- Jan 2011
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial of levosimendan in septic shock, sponsored by Military Hospital of Tunis. Primary endpoint: Glucose concentration in extracellular fluid at 72 hours. Status: unknown.
02
Drugs
levosimendan
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02963454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963454.